Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -48.94% is 20% above its 5-year average of -60.83%, around the middle of its 5-year range (-188.79%–20.25%).
38.70% below its 12-month average of -35.28%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -45.85%.
NET PROFIT MARGIN
-48.94%
NET PROFIT MARGIN AVG TTM
-35.28%
NET PROFIT MARGIN AVG 3Y
-59.21%
NET PROFIT MARGIN AVG 5Y
-60.83%
NET PROFIT MARGIN AVG 10Y
-67.08%
NET PROFIT MARGIN AVG 15Y
-80.95%
NET PROFIT MARGIN AVG 20Y
-59.29%
CURRENT VS TTM AVG
-38.70%
CURRENT VS 3Y AVG
+17.35%
CURRENT VS 5Y AVG
+19.55%
CURRENT VS 10Y AVG
+27.04%
CURRENT VS 15Y AVG
+39.55%
CURRENT VS 20Y AVG
+17.46%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 722 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cytosorbents Corporation
Market Cap
$12.60M
Net Profit Margin
-48.94%
TTM Avg
-35.28%
3Y Avg
-59.21%
5Y Avg
-60.83%
Market Cap
$12.56M
Net Profit Margin
-804.37%
TTM Avg
-21365.78%
3Y Avg
-11028.80%
5Y Avg
-7352.54%
Market Cap
$12.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.76M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.12M
Net Profit Margin
-6.88%
TTM Avg
-8.42%
3Y Avg
-15.06%
5Y Avg
-13.62%
Market Cap
$11.37M
Net Profit Margin
-2006.87%
TTM Avg
-2784.80%
3Y Avg
-10458.57%
5Y Avg
-6972.38%
Market Cap
$11.81M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.48M
Net Profit Margin
-3972.87%
TTM Avg
-1209.50%
3Y Avg
-3598.61%
5Y Avg
-2399.08%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.60M | -48.94% | -35.28% | -59.21% | -60.83% |
| Dare Bioscience, Inc. (DARE)vs › | $12.56M | -804.37% | -21365.78% | -11028.80% | -7352.54% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lantern Pharma Inc. (LTRN)vs › | $12.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $12.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| IRIDEX Corporation (IRIX)vs › | $12.12M | -6.88% | -8.42% | -15.06% | -13.62% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.37M | -2006.87% | -2784.80% | -10458.57% | -6972.38% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| Optimi Health Corp. (OPTH)vs › | $13.48M | -3972.87% | -1209.50% | -3598.61% | -2399.08% |
| Biofrontera Inc. (BFRI)vs › | $11.38M | -13.78% | -36.44% | -33.55% | -58.16% |
Operating Margin
-33.4%
Net Profit Margin
-48.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -45.85% |
| 2026-03-31 | -57.86% |
| 2025-12-31 | -59.53% |
| 2025-09-30 | -33.42% |
| 2025-06-30 | 20.25% |
| 2025-03-31 | -16.94% |
| 2024-12-31 | -86.16% |
| 2024-09-30 | -27.10% |
| 2024-06-30 | -48.56% |
| 2024-03-31 | -67.73% |
| 2023-12-31 | -83.48% |
| 2023-09-30 | -118.56% |
| 2023-06-30 | -65.31% |
| 2023-03-31 | -77.53% |
| 2022-12-31 | -8.16% |
| 2022-09-30 | -188.79% |
| 2022-06-30 | -128.06% |
| 2022-03-31 | -113.15% |
| 2021-12-31 | -86.32% |
| 2021-09-30 | -71.97% |
| 2021-06-30 | -41.16% |
| 2021-03-31 | -41.09% |
| 2020-12-31 | -5.67% |
| 2020-09-30 | -8.20% |
| 2020-06-30 | -30.11% |
| 2020-03-31 | -42.34% |
| 2019-12-31 | -59.74% |
| 2019-09-30 | -120.20% |
| 2019-06-30 | -60.63% |
| 2019-03-31 | -106.71% |
| 2018-12-31 | -98.76% |
| 2018-09-30 | -58.89% |
| 2018-06-30 | -110.96% |
| 2018-03-31 | -67.27% |
| 2017-12-31 | -73.25% |
| 2017-09-30 | -59.55% |
| 2017-06-30 | -36.70% |
| 2017-03-31 | -53.08% |
| 2016-12-31 | -145.89% |
| 2016-09-30 | -125.20% |
| 2016-06-30 | -162.17% |
| 2016-03-31 | -114.97% |
| 2015-12-31 | -133.82% |
| 2015-09-30 | -265.83% |
| 2015-06-30 | 182.84% |
| 2015-03-31 | -669.56% |
| 2014-12-31 | -571.74% |
| 2014-09-30 | -144.87% |
| 2014-06-30 | -278.49% |
| 2014-03-31 | -170.78% |
| 2013-12-31 | -212.95% |
| 2013-09-30 | -474.06% |
| 2013-06-30 | -1105.74% |
| 2013-03-31 | -925.05% |
| 2012-12-31 | 91.65% |
| 2012-09-30 | -107.71% |
| 2012-06-30 | -3168.69% |
| 2012-03-31 | -8447.29% |
| 2011-12-31 | -3317.81% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 19782.87% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-02-28 | -261.64% |
| 2005-11-30 | -164.03% |
| 2005-08-31 | -24273.89% |
| 2005-05-31 | 0.00% |
| 2005-02-28 | 0.00% |
| 2004-11-30 | 0.00% |
